UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition

Nature communications, 2021-05, Vol.12 (1), p.2498-2498, Article 2498

2021

Volltextzugriff (PDF)

Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells

Clinical cancer research, 2017-05, Vol.23 (9), p.2277-2288

2017

Volltextzugriff (PDF)

Expression and Functional Regulation of Myoglobin in Epithelial Cancers

The American journal of pathology, 2009-07, Vol.175 (1), p.201-206

2009

Volltextzugriff (PDF)

Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary

EMBO molecular medicine, 2023-03, Vol.15 (3), p.e16104-n/a

2023

Volltextzugriff (PDF)

Cytokine-Induced Killer Cells Eradicate Bone and Soft-Tissue Sarcomas

Cancer research (Chicago, Ill.), 2014, Vol.74 (1), p.119-129

2014

Volltextzugriff (PDF)

Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations

Clinical cancer research, 2011-05, Vol.17 (10), p.3146-3156

2011

Volltextzugriff (PDF)

Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report

EMBO molecular medicine, 2020-07, Vol.12 (7), p.e11756-n/a

2020

Volltextzugriff (PDF)

CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma

Journal of experimental & clinical cancer research, 2023-11, Vol.42 (1), p.1-310, Article 310

2023

Volltextzugriff (PDF)

Ab-Induced Ectodomain Shedding Mediates Hepatocyte Growth Factor Receptor down-Regulation and Hampers Biological Activity

Proceedings of the National Academy of Sciences - PNAS, 2006-03, Vol.103 (13), p.5090-5095

2006

Volltextzugriff (PDF)

Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy

Oncoimmunology, 2018-11, Vol.7 (11), p.e1465161-e1465161

2018

Volltextzugriff (PDF)

Genetic targeting of the kinase activity of the Met receptor in cancer cells

Proceedings of the National Academy of Sciences - PNAS, 2007-07, Vol.104 (27), p.11412-11417

2007

Volltextzugriff (PDF)

Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas

Clinical cancer research, 2012-05, Vol.18 (9), p.2515-2525

2012

Volltextzugriff (PDF)

CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes

Clinical cancer research, 2020-12, Vol.26 (23), p.6321-6334

2020

Volltextzugriff (PDF)

Effective Activity of Cytokine-Induced Killer Cells against Autologous Metastatic Melanoma Including Cells with Stemness Features

Clinical cancer research, 2013-08, Vol.19 (16), p.4347-4358

2013

Volltextzugriff (PDF)

A pancreatic metastasis from a colon carcinoma mimicking a primary tumor diagnosed by EUS-guided fine-needle biopsy

Endoscopic Ultrasound, 2023-01, Vol.12 (1), p.162-163

2023

Volltextzugriff (PDF)

Abstract 2871: Hypermetastatic stem-like cells from 'cancer of unknown primary' (CUP) model multi-organ dissemination and unveil liability to MEK inhibition

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2871-2871

2021

Volltextzugriff (PDF)

HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction

Molecular cancer therapeutics, 2020-12, Vol.19 (12), p.2476-2489

2020

Volltextzugriff (PDF)

Impact of upfront multidisciplinary tumor board (MTB) evaluation on breast sarcoma (BS) outcome

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e23546-e23546

2020

Volltextzugriff (PDF)

Abstract 569: Expression and modulation by IFN of HLA class I APM components in melanoma: Potential biomarkers of clinical response to checkpoint inhibitors

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.569-569

2019

Volltextzugriff (PDF)

Abstract 2290: Effective immunotherapy with cytokine-induced killer cells against autologous melanoma cancer stem cells

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.2290-2290

2016

Volltextzugriff (PDF)

Abstract 2812: CSPG4-specific CAR.CIK lymphocyte-based immunotherapy to eliminate HLA class I-defective melanoma tumors

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2812-2812

2022

Volltextzugriff (PDF)

In melanocytic lesions the fraction of BRAF V600E alleles is associated with sun exposure but unrelated to ERK phosphorylation

Modern pathology, 2008-06, Vol.21 (6), p.716

2008

Volltextzugriff (PDF)

In melanocytic lesions the fraction of BRAFV600E alleles is associated with sun exposure but unrelated to ERK phosphorylation

Modern pathology, 2008-06, Vol.21 (6), p.716-726

2008

Volltextzugriff (PDF)

HER2 and Central Nervous System Metastasis in Patients with Breast Cancer

Clinical breast cancer, 2004-08, Vol.5 (3), p.232-234

2004

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

KollektionWiley Online Library Full Collection 2018

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)

Publikationsform

Sprache

Englisch
(28)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition

A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer

Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells

Expression and Functional Regulation of Myoglobin in Epithelial Cancers

Mutated axon guidance gene PLXNB2 sustains growth and invasiveness of stem cells isolated from cancers of unknown primary

Cytokine-Induced Killer Cells Eradicate Bone and Soft-Tissue Sarcomas

Genetic and Expression Analysis of MET, MACC1, and HGF in Metastatic Colorectal Cancer: Response to Met Inhibition in Patient Xenografts and Pathologic Correlations

Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report

CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma

Ab-Induced Ectodomain Shedding Mediates Hepatocyte Growth Factor Receptor down-Regulation and Hampers Biological Activity

Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy

Genetic targeting of the kinase activity of the Met receptor in cancer cells

Inhibition of MEK and PI3K/mTOR Suppresses Tumor Growth but Does Not Cause Tumor Regression in Patient-Derived Xenografts of RAS-Mutant Colorectal Carcinomas

CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes

Effective Activity of Cytokine-Induced Killer Cells against Autologous Metastatic Melanoma Including Cells with Stemness Features

A pancreatic metastasis from a colon carcinoma mimicking a primary tumor diagnosed by EUS-guided fine-needle biopsy

Abstract 2871: Hypermetastatic stem-like cells from 'cancer of unknown primary' (CUP) model multi-organ dissemination and unveil liability to MEK inhibition

HIV Protease Inhibitors Block HPV16-Induced Murine Cervical Carcinoma and Promote Vessel Normalization in Association with MMP-9 Inhibition and TIMP-3 Induction

Impact of upfront multidisciplinary tumor board (MTB) evaluation on breast sarcoma (BS) outcome

Abstract 569: Expression and modulation by IFN of HLA class I APM components in melanoma: Potential biomarkers of clinical response to checkpoint inhibitors

Abstract 2290: Effective immunotherapy with cytokine-induced killer cells against autologous melanoma cancer stem cells

Abstract 2812: CSPG4-specific CAR.CIK lymphocyte-based immunotherapy to eliminate HLA class I-defective melanoma tumors

In melanocytic lesions the fraction of BRAF V600E alleles is associated with sun exposure but unrelated to ERK phosphorylation

In melanocytic lesions the fraction of BRAFV600E alleles is associated with sun exposure but unrelated to ERK phosphorylation

HER2 and Central Nervous System Metastasis in Patients with Breast Cancer

Aktive Filter

Suchergebnisse filtern